市場調査レポート
商品コード
1150085

希少疾患遺伝子検査の世界市場 - 市場シェア・規模・動向・業界分析:専門分野別、技術別、疾患タイプ別、最終用途別、地域別、セグメント予測(2022年~2030年)

Rare Disease Genetic Testing Market Share, Size, Trends, Industry Analysis Report, By Specialty ; By Technology; By Disease Type; By End-Use; By Region; Segment Forecast, 2022 - 2030

出版日: | 発行: Polaris Market Research | ページ情報: 英文 119 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
希少疾患遺伝子検査の世界市場 - 市場シェア・規模・動向・業界分析:専門分野別、技術別、疾患タイプ別、最終用途別、地域別、セグメント予測(2022年~2030年)
出版日: 2022年10月01日
発行: Polaris Market Research
ページ情報: 英文 119 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の希少疾患遺伝子検査の市場規模は、2030年までに24億1,490万米ドルに達すると予測されています。

当レポートでは、世界の希少疾患遺伝子検査市場を調査しており、市場の概要、市場規模や予測、動向、促進要因・抑制要因、専門分野別・技術別・疾患タイプ別・最終用途別・地域別などの分析、さらに企業プロファイルなどを提供しています。

目次

第1章 イントロダクション

  • レポートの説明
    • 調査の目的
    • 市場範囲
    • 前提条件
  • 利害関係者

第2章 エグゼクティブサマリー

  • 市場のハイライト

第3章 調査手法

  • 概要
    • データマイニング
  • 情報源
    • 一次情報
    • 二次情報

第4章 世界の希少疾患遺伝子検査市場の洞察

  • 希少疾患遺伝子検査 - 業界のスナップショット
  • 希少疾患遺伝子検査市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターのファイブフォース分析
    • 供給企業の交渉力
    • 新規参入者の脅威
    • 買い手の交渉力
    • 代替品の脅威
    • 既存企業間の競争力
  • PESTLE分析
  • 希少疾患遺伝子検査業界の動向
  • バリューチェーン分析
  • COVID-19影響分析

第5章 世界の希少疾患遺伝子検査市場:技術別

  • 主な調査結果
  • イントロダクション
    • 世界の希少疾患遺伝子検査市場、技術別(2018年~2030年)
  • 次世代シーケンシング
    • 世界の希少疾患遺伝子検査市場、次世代シーケンシング別、地域別(2018年~2030年)
    • 全エクソーム
    • 全ゲノム
  • アレイ技術
    • 世界の希少疾患遺伝子検査市場、アレイ技術別、地域別(2018年~2030年)
  • PCRベース検査
    • 世界の希少疾患遺伝子検査市場、PCRベース検査別、地域別(2018年~2030年)
  • FISH
    • 世界の希少疾患遺伝子検査市場、FISH別、地域別(2018年~2030年)
  • サンガーシーケンシング
    • 世界の希少疾患遺伝子検査市場、サンガーシーケンシング別、地域別(2018年~2030年)
  • 核型分析
    • 世界の希少疾患遺伝子検査市場、核型分析別、地域別(2018年~2030年)

第6章 世界の希少疾患遺伝子検査市場:専門分野別

  • 主な調査結果
  • イントロダクション
    • 世界の希少疾患遺伝子検査市場、専門分野別(2018年~2030年)
  • 分子遺伝学的検査
    • 世界の希少疾患遺伝子検査市場、分子遺伝学的検査別、地域別(2018年~2030年)
  • 染色体遺伝子検査
    • 世界の希少疾患遺伝子検査市場、染色体遺伝子検査別、地域別(2018年~2030年)
  • 生化学的遺伝子検査
    • 世界の希少疾患遺伝子検査市場、生化学的遺伝子検査別、地域別(2018年~2030年)

第7章 世界の希少疾患遺伝子検査市場:疾患タイプ別

  • 主な調査結果
  • イントロダクション
    • 世界の希少疾患遺伝子検査市場、疾患タイプ別(2018年~2030年)
  • 神経疾患
    • 世界の希少疾患遺伝子検査市場、神経疾患別、地域別(2018年~2030年)
  • 免疫疾患
    • 世界の希少疾患遺伝子検査市場、免疫疾患別、地域別(2018年~2030年)
  • 血液疾患
    • 世界の希少疾患遺伝子検査市場、血液疾患別、地域別(2018年~2030年)
  • 内分泌・代謝疾患
    • 世界の希少疾患遺伝子検査市場、内分泌・代謝疾患別、地域別(2018年~2030年)
  • がん
    • 世界の希少疾患遺伝子検査市場、がん別、地域別(2018年~2030年)
  • 筋骨格系疾患
    • 世界の希少疾患遺伝子検査市場、筋骨格系疾患別、地域別(2018年~2030年)
  • 心血管疾患
    • 世界の希少疾患遺伝子検査市場、心血管疾患別、地域別(2018年~2030年)
  • 皮膚疾患
    • 世界の希少疾患遺伝子検査市場、皮膚疾患別、地域別(2018年~2030年)
  • その他
    • 世界の希少疾患遺伝子検査市場、その他別、地域別(2018年~2030年)

第8章 世界の希少疾患遺伝子検査市場:最終用途別

  • 主な調査結果
  • イントロダクション
    • 世界の希少疾患遺伝子検査市場、最終用途別(2018年~2030年)
  • 研究ラボ・CRO
    • 世界の希少疾患遺伝子検査市場、研究ラボ・CRO別、地域別(2018年~2030年)
  • 病院・診療所
    • 世界の希少疾患遺伝子検査市場、病院・診療所別、地域別(2018年~2030年)
  • 診断ラボ
    • 世界の希少疾患遺伝子検査市場、診断ラボ別、地域別(2018年~2030年)

第9章 世界の希少疾患遺伝子検査市場:地域別

  • 主な調査結果
  • イントロダクション
    • 希少疾患遺伝子検査市場の評価、地域別(2018年~2030年)
  • 希少疾患遺伝子検査市場 - 北米
    • 北米:希少疾患遺伝子検査市場、技術別(2018年~2030年)
    • 北米:希少疾患遺伝子検査市場、最終用途別(2018年~2030年)
    • 北米:希少疾患遺伝子検査市場、専門分野別(2018年~2030年)
    • 北米:希少疾患遺伝子検査市場、疾患タイプ別(2018年~2030年)
    • 希少疾患遺伝子検査市場 - 米国
    • 希少疾患遺伝子検査市場 - カナダ
  • 希少疾患遺伝子検査市場 - 欧州
    • 欧州:希少疾患遺伝子検査市場、技術別(2018年~2030年)
    • 欧州:希少疾患遺伝子検査市場、最終用途別(2018年~2030年)
    • 欧州:希少疾患遺伝子検査市場、専門分野別(2018年~2030年)
    • 欧州:希少疾患遺伝子検査市場、疾患タイプ別(2018年~2030年)
    • 希少疾患遺伝子検査市場 - 英国
    • 希少疾患遺伝子検査市場 - フランス
    • 希少疾患遺伝子検査市場 - ドイツ
    • 希少疾患遺伝子検査市場 - イタリア
    • 希少疾患遺伝子検査市場 - スペイン
    • 希少疾患遺伝子検査市場 - オランダ
    • 希少疾患遺伝子検査市場 - ロシア
  • 希少疾患遺伝子検査市場 - アジア太平洋
    • アジア太平洋:希少疾患遺伝子検査市場、技術別(2018年~2030年)
    • アジア太平洋:希少疾患遺伝子検査市場、最終用途別(2018年~2030年)
    • アジア太平洋:希少疾患遺伝子検査市場、専門分野別(2018年~2030年)
    • アジア太平洋:希少疾患遺伝子検査市場、疾患タイプ別(2018年~2030年)
    • 希少疾患遺伝子検査市場 - 中国
    • 希少疾患遺伝子検査市場 - インド
    • 希少疾患遺伝子検査市場 - 日本
    • 希少疾患遺伝子検査市場 - マレーシア
    • 希少疾患遺伝子検査市場 - インドネシア
    • 希少疾患遺伝子検査市場 - 韓国
  • 希少疾患遺伝子検査市場 - 中東・アフリカ
    • 中東・アフリカ:希少疾患遺伝子検査市場、技術別(2018年~2030年)
    • 中東・アフリカ:希少疾患遺伝子検査市場、最終用途別(2018年~2030年)
    • 中東・アフリカ:希少疾患遺伝子検査市場、専門分野別(2018年~2030年)
    • 中東・アフリカ:希少疾患遺伝子検査市場、疾患タイプ別(2018年~2030年)
    • 希少疾患遺伝子検査市場 - サウジアラビア
    • 希少疾患遺伝子検査市場 - 南アフリカ
    • 希少疾患遺伝子検査市場 - イスラエル
    • 希少疾患遺伝子検査市場 - アラブ首長国連邦
  • 希少疾患遺伝子検査市場 - ラテンアメリカ
    • ラテンアメリカ:希少疾患遺伝子検査市場、技術別(2018年~2030年)
    • ラテンアメリカ:希少疾患遺伝子検査市場、最終用途別(2018年~2030年)
    • ラテンアメリカ:希少疾患遺伝子検査市場、専門分野別(2018年~2030年)
    • ラテンアメリカ:希少疾患遺伝子検査市場、疾患タイプ別(2018年~2030年)
    • 希少疾患遺伝子検査市場 - メキシコ
    • 希少疾患遺伝子検査市場 - ブラジル
    • 希少疾患遺伝子検査市場 - アルゼンチン

第10章 競合情勢

  • 拡大・買収の分析
    • 拡大
    • 買収
  • パートナーシップ/コラボレーション/協定/公開

第11章 企業プロファイル

  • 3billion, Inc
  • Ambry Genetics
  • Artemis DNA
  • Arup Laboratories
  • Baylor Genetics
  • Centogene N.V
  • Color Genomics, Inc
  • Coopersurgical, Inc
  • Eurofins Scientific
  • Fulgent Genetics Inc
  • Genomenon
  • Health Network Laboratories
  • Invitae Corp
  • Laboratory Corporation of America Holdings
  • Macrogen, Inc
  • Myriad Genetics, Inc.
  • Opko Health, Inc
  • Perkin Elmer, Inc
  • PreventionGenetics
  • Progenity, Inc
  • Quest Diagnostics Inc.
  • Realm IDX, Inc
  • Strand Life Sciences.
図表

List of Tables

  • Table 1 Global Rare Disease Genetic Testing Market, by Technology, by Region, 2018 - 2030 (USD Million)
  • Table 2 Global Rare Disease Genetic Testing Market, by Specialty, by Region, 2018 - 2030 (USD Million)
  • Table 3 Global Rare Disease Genetic Testing Market, by Disease Type, by Region, 2018 - 2030 (USD Million)
  • Table 4 Global Rare Disease Genetic Testing Market, by End-use, by Region, 2018 - 2030 (USD Million)
  • Table 5 Rare Disease Genetic Testing Market Assessment, By Geography, 2018 - 2030 (USD Million)
  • Table 6 North America: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 7 North America: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
  • Table 8 North America: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
  • Table 9 North America: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 10 U.S.: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 11 U.S.: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
  • Table 12 U.S.: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
  • Table 13 U.S.: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 14 Canada: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 15 Canada: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
  • Table 16 Canada: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
  • Table 17 Canada: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 18 Europe: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 19 Europe: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
  • Table 20 Europe: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
  • Table 21 Europe: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 22 Germany: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 23 Germany: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
  • Table 24 Germany: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
  • Table 25 Germany: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 26 France: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 27 France: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
  • Table 28 France: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
  • Table 29 France: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 30 UK: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 31 UK: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
  • Table 32 UK: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
  • Table 33 UK: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 34 Italy: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 35 Italy: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
  • Table 36 Italy: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
  • Table 37 Italy: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 38 Netherlands: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 39 Netherlands: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
  • Table 40 Netherlands: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
  • Table 41 Netherlands: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 42 Spain: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 43 Spain: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
  • Table 44 Spain: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
  • Table 45 Spain: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 46 Russia: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 47 Russia: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
  • Table 48 Russia: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
  • Table 49 Russia: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
  • Table 52 Asia Pacific: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
  • Table 53 Asia Pacific: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 54 China: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 55 China: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
  • Table 56 China: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
  • Table 57 China: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 58 Japan: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 59 Japan: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
  • Table 60 Japan: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
  • Table 61 Japan: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 62 India: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 63 India: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
  • Table 64 India: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
  • Table 65 India: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 66 Indonesia: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 67 Indonesia: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
  • Table 68 Indonesia: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
  • Table 69 Indonesia: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 70 Malaysia: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 71 Malaysia: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
  • Table 72 Malaysia: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
  • Table 73 Malaysia: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 74 South Korea: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 75 South Korea: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
  • Table 76 South Korea: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
  • Table 77 South Korea: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 78 Latin America: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 79 Latin America: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
  • Table 80 Latin America: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
  • Table 81 Latin America: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 82 Brazil: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 83 Brazil: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
  • Table 84 Brazil: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
  • Table 85 Brazil: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 86 Mexico: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 87 Mexico: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
  • Table 88 Mexico: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
  • Table 89 Mexico: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 90 Argentina: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 91 Argentina: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
  • Table 92 Argentina: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
  • Table 93 Argentina: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 94 Middle East & Africa: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 95 Middle East & Africa: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
  • Table 96 Middle East & Africa: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
  • Table 97 Middle East & Africa: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 98 UAE: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 99 UAE: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
  • Table 100 UAE: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
  • Table 101 UAE: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 102 Saudi Arabia: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 103 Saudi Arabia: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
  • Table 104 Saudi Arabia: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
  • Table 105 Saudi Arabia: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 106 South Africa: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 107 South Africa: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
  • Table 108 South Africa: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
  • Table 109 South Africa: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 110 Israel: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 111 Israel: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
  • Table 112 Israel: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
  • Table 113 Israel: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)

List of Figures

Figure 1. Global Rare Disease Genetic Testing Market, 2018 - 2030 (USD Million)

Figure 2. Integrated Ecosystem

Figure 3. Research Methodology: Top-Down & Bottom-Up End-use

Figure 4. Market by Geography

Figure 5. Porter's Five Forces

Figure 6. Market by Technology

Figure 7. Global Rare Disease Genetic Testing Market, by Technology, 2021 & 2030 (USD Million)

Figure 8. Market by End-use

Figure 9. Global Rare Disease Genetic Testing Market, by End-use, 2021 & 2030 (USD Million)

Figure 10. Market by Specialty

Figure 11. Global Rare Disease Genetic Testing Market, by Specialty, 2021 & 2030 (USD Million)

Figure 12. Market by Disease Type

Figure 13. Global Rare Disease Genetic Testing Market, by Disease Type, 2021 & 2030 (USD Million)

Figure 14. Rare Disease Genetic Testing Market Assessment, By Geography, 2018 - 2030 (USD Million)

Figure 15. Strategic Analysis - Rare Disease Genetic Testing Market

目次
Product Code: PM1772

The global rare disease genetic testing market size is expected to reach USD 2,414.90 million by 2030 according to a new study by Polaris Market Research. The report "Rare Disease Genetic Testing Market Share, Size, Trends, Industry Analysis Report, By Specialty (Molecular Genetic Tests, Chromosomal Genetic Tests, Biochemical Genetic Tests); By Technology; By Disease Type; By End-Use; By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Increasing technological advancements, including NGS and microarray, are prominent factors responsible for the market's growth. Also, the existence of Rare Diseases Clinical Research Network (RDCRN), an NIH-funded research network of 23 active research groups focused on the diagnosis & treatment of disorders, is anticipated to impact the industry positively. Furthermore, the decline in sequencing prices has shifted the attention to testing rare diseases, which has influenced the adoption of NGS, resulting in the market's growth.

Translational research and genomic technologies play a crucial role in accelerating the investigation and identification of new mutations, which aid in market expansion. Due to numerous translational research activities in this field, genetic testing in disease diagnostics is expected to rise rapidly throughout the projection period.

An increase in patient registry for rare diseases and development of new products to treat rare diseases are stimulating the growth of the market. The market is expected to grow as the number and quality of available registries continue to expand. So advanced data collection and interpretation technologies that can be used in clinical practices improve. An increasing number of patients undergoing disease testing, as well as increased government assistance, will fuel several new opportunities for market growth.

Rare Disease Genetic Testing Market Report Highlights

Endocrine and metabolism disease witnessed the largest market share in 2021 due to the growing number of patients with Cushing's syndrome.

The next-generation sequencing segment acquires significant market share due to increasing medical acceptance of whole exome sequencing-based gene tests.

Molecular genetic test segment is anticipated to hold considerable market share during the forecast period due to advanced testing technologies such as genome sequencing, which is affordable.

Research labs & CROs accounted largest market share in 2021 due to a large number of genetic tests performed in research laboratories and CROs.

North America dominated the market in 2021 due to the high prevalence of rare diseases and the abundance of registries in this region.

The global market is highly competitive owing to the existence of large industry players with a global presence of 3billion, Inc., Ambry Genetics, Artemis DNA, Arup Laboratories, Baylor Genetics, Centogene N.V., Color Genomics, Inc., Coopersurgical, Inc., Eurofins Scientific, Fulgent Genetics Inc., Genomenon, Health Network Laboratories, Invitae Corp., Laboratory Corporation of America Holdings, Macrogen, Inc., Myriad Genetics, Inc., Opko Health, Inc., Perkin Elmer, Inc., PreventionGenetics, Progenity, Inc., Quest Diagnostics Inc., Realm IDX, Inc., and Strand Life Sciences.

Polaris Market Research has segmented the rare disease genetic testing market report based on disease type, technology, specialty, end-use, and regions:

Rare Disease Genetic Testing, Disease Type Outlook (Revenue - USD Million, 2018 - 2030)

Neurological disease

Immunological disorders

Hematology diseases

Endocrine and metabolism diseases

Cancer

Musculoskeletal disorders

Cardiovascular disorders

Dermatological disease

Others

Rare Disease Genetic Testing, Technology Outlook (Revenue - USD Million, 2018 - 2030)

Next-generation sequencing

Whole Exome

Whole Genome

Array Technology

PCR-based testing

FISH

Sanger Sequencing

Karyotyping

Rare Disease Genetic Testing, Specialty Outlook (Revenue - USD Million, 2018 - 2030)

Molecular genetic tests

Chromosomal genetic tests

Biochemical genetic tests

Rare Disease Genetic Testing, End-Use Outlook (Revenue - USD Million, 2018 - 2030)

Research Lab and CROs

Hospitals and Clinics

Diagnostic Laboratories

Rare Disease Genetic Testing, Regional Outlook (Revenue - USD Million, 2018 - 2030)

North America

U.S

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Rare Disease Genetic Testing Market Insights

  • 4.1. Rare Disease Genetic Testing - Industry Snapshot
  • 4.2. Rare Disease Genetic Testing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Expanding patient registry for rare disease
      • 4.2.1.2. Government & Regulatory Support For Rare Disease Diagnosis
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Limited Awareness about The Rare Disease Conditions
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Rare Disease Genetic Testing Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Rare Disease Genetic Testing Market, by Technology

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
  • 5.3. Next-Generation Sequencing
    • 5.3.1. Global Rare Disease Genetic Testing Market, by Next-Generation Sequencing, by Region, 2018 - 2030 (USD Million)
    • 5.3.2. Whole Exome
      • 5.3.2.1. Global Rare Disease Genetic Testing Market, by Whole Exome, by Region, 2018 - 2030 (USD Million)
    • 5.3.3. Whole Genome
      • 5.3.3.1. Global Rare Disease Genetic Testing Market, by Whole Genome, by Region, 2018 - 2030 (USD Million)
  • 5.4. Array Technology
    • 5.4.1. Global Rare Disease Genetic Testing Market, by Array Technology, by Region, 2018 - 2030 (USD Million)
  • 5.5. PCR-based Testing
    • 5.5.1. Global Rare Disease Genetic Testing Market, by PCR-based Testing, by Region, 2018 - 2030 (USD Million)
  • 5.6. FISH
    • 5.6.1. Global Rare Disease Genetic Testing Market, by FISH, by Region, 2018 - 2030 (USD Million)
  • 5.7. Sanger Sequencing
    • 5.7.1. Global Rare Disease Genetic Testing Market, by Sanger Sequencing, by Region, 2018 - 2030 (USD Million)
  • 5.8. Karyotyping
    • 5.8.1. Global Rare Disease Genetic Testing Market, by Karyotyping, by Region, 2018 - 2030 (USD Million)

6. Global Rare Disease Genetic Testing Market, by Specialty

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
  • 6.3. Molecular Genetic Tests
    • 6.3.1. Global Rare Disease Genetic Testing Market, by Molecular Genetic Tests, by Region, 2018 - 2030 (USD Million)
  • 6.4. Chromosomal Genetic Tests
    • 6.4.1. Global Rare Disease Genetic Testing Market, by Chromosomal Genetic Tests, by Region, 2018 - 2030 (USD Million)
  • 6.5. Biochemical, Genetic Tests
    • 6.5.1. Global Rare Disease Genetic Testing Market, by Biochemical, Genetic Tests, by Region, 2018 - 2030 (USD Million)

7. Global Rare Disease Genetic Testing Market, by Disease Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
  • 7.3. Neurological Disease
    • 7.3.1. Global Rare Disease Genetic Testing Market, by Neurological Disease, by Region, 2018 - 2030 (USD Million)
  • 7.4. Immunological Disorders
    • 7.4.1. Global Rare Disease Genetic Testing Market, by Immunological Disorders, by Region, 2018 - 2030 (USD Million)
  • 7.5. Hematology Diseases
    • 7.5.1. Global Rare Disease Genetic Testing Market, by Hematology Diseases, by Region, 2018 - 2030 (USD Million)
  • 7.6. Endocrine & Metabolism Diseases
    • 7.6.1. Global Rare Disease Genetic Testing Market, by Endocrine & Metabolism Diseases, by Region, 2018 - 2030 (USD Million)
  • 7.7. Cancer
    • 7.7.1. Global Rare Disease Genetic Testing Market, by Cancer, by Region, 2018 - 2030 (USD Million)
  • 7.8. Musculoskeletal Disorders
    • 7.8.1. Global Rare Disease Genetic Testing Market, by Musculoskeletal Disorders, by Region, 2018 - 2030 (USD Million)
  • 7.9. Cardiovascular Disorders
    • 7.9.1. Global Rare Disease Genetic Testing Market, by Cardiovascular Disorders, by Region, 2018 - 2030 (USD Million)
  • 7.10. Dermatology Disease
    • 7.10.1. Global Rare Disease Genetic Testing Market, by Dermatology Disease, by Region, 2018 - 2030 (USD Million)
  • 7.11. Others
    • 7.11.1. Global Other Rare Disease Genetic Testing Market, by Region, 2018 - 2030 (USD Million)

8. Global Rare Disease Genetic Testing Market, by End-use

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
  • 8.3. Research Laboratories & Cros
    • 8.3.1. Global Rare Disease Genetic Testing Market, by Research Laboratories & Cros, by Region, 2018 - 2030 (USD Million)
  • 8.4. Hospitals & Clinics
    • 8.4.1. Global Rare Disease Genetic Testing Market, by Hospitals & Clinics, by Region, 2018 - 2030 (USD Million)
  • 8.5. Diagnostic Laboratories
    • 8.5.1. Global Rare Disease Genetic Testing Market, by Diagnostic Laboratories, by Region, 2018 - 2030 (USD Million)

9. Global Rare Disease Genetic Testing Market, by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Rare Disease Genetic Testing Market Assessment, By Geography, 2018 - 2030 (USD Million)
  • 9.3. Rare Disease Genetic Testing Market - North America
    • 9.3.1. North America: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
    • 9.3.2. North America: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
    • 9.3.3. North America: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
    • 9.3.4. North America: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
    • 9.3.5. Rare Disease Genetic Testing Market - U.S.
      • 9.3.5.1. U.S.: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
      • 9.3.5.2. U.S.: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
      • 9.3.5.3. U.S.: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
      • 9.3.5.4. U.S.: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
    • 9.3.6. Rare Disease Genetic Testing Market - Canada
      • 9.3.6.1. Canada: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
      • 9.3.6.2. Canada: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
      • 9.3.6.3. Canada: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
      • 9.3.6.4. Canada: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
  • 9.4. Rare Disease Genetic Testing Market - Europe
    • 9.4.1. Europe: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
    • 9.4.2. Europe: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
    • 9.4.3. Europe: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
    • 9.4.4. Europe: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
    • 9.4.5. Rare Disease Genetic Testing Market - UK
      • 9.4.5.1. UK: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
      • 9.4.5.2. UK: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
      • 9.4.5.3. UK: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
      • 9.4.5.4. UK: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
    • 9.4.6. Rare Disease Genetic Testing Market - France
      • 9.4.6.1. France: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
      • 9.4.6.2. France: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
      • 9.4.6.3. France: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
      • 9.4.6.4. France: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
    • 9.4.7. Rare Disease Genetic Testing Market - Germany
      • 9.4.7.1. Germany: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
      • 9.4.7.2. Germany: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
      • 9.4.7.3. Germany: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
      • 9.4.7.4. Germany: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
    • 9.4.8. Rare Disease Genetic Testing Market - Italy
      • 9.4.8.1. Italy: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
      • 9.4.8.2. Italy: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
      • 9.4.8.3. Italy: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
      • 9.4.8.4. Italy: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
    • 9.4.9. Rare Disease Genetic Testing Market - Spain
      • 9.4.9.1. Spain: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
      • 9.4.9.2. Spain: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
      • 9.4.9.3. Spain: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
      • 9.4.9.4. Spain: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
    • 9.4.10. Rare Disease Genetic Testing Market - Netherlands
      • 9.4.10.1. Netherlands: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
      • 9.4.10.2. Netherlands: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
      • 9.4.10.3. Netherlands: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
      • 9.4.10.4. Netherlands: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
    • 9.4.11. Rare Disease Genetic Testing Market - Russia
      • 9.4.11.1. Russia: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
      • 9.4.11.2. Russia.: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
      • 9.4.11.3. Russia: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
      • 9.4.11.4. Russia: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
  • 9.5. Rare Disease Genetic Testing Market - Asia Pacific
    • 9.5.1. Asia Pacific: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
    • 9.5.2. Asia Pacific: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
    • 9.5.3. Asia Pacific: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
    • 9.5.4. Asia Pacific: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
    • 9.5.5. Rare Disease Genetic Testing Market - China
      • 9.5.5.1. China: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
      • 9.5.5.2. China.: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
      • 9.5.5.3. China: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
      • 9.5.5.4. China: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
    • 9.5.6. Rare Disease Genetic Testing Market - India
      • 9.5.6.1. India: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
      • 9.5.6.2. India.: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
      • 9.5.6.3. India: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
      • 9.5.6.4. India: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
    • 9.5.7. Rare Disease Genetic Testing Market - Japan
      • 9.5.7.1. Japan: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
      • 9.5.7.2. Japan.: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
      • 9.5.7.3. Japan: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
      • 9.5.7.4. Japan: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
    • 9.5.8. Rare Disease Genetic Testing Market - Malaysia
      • 9.5.8.1. Malaysia: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
      • 9.5.8.2. Malaysia.: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
      • 9.5.8.3. Malaysia: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
      • 9.5.8.4. Malaysia: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
    • 9.5.9. Rare Disease Genetic Testing Market - Indonesia
      • 9.5.9.1. Indonesia: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
      • 9.5.9.2. Indonesia.: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
      • 9.5.9.3. Indonesia: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
      • 9.5.9.4. Indonesia: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
    • 9.5.10. Rare Disease Genetic Testing Market - South Korea
      • 9.5.10.1. South Korea: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
      • 9.5.10.2. South Korea.: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
      • 9.5.10.3. South Korea: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
      • 9.5.10.4. South Korea: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
  • 9.6. Rare Disease Genetic Testing Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
    • 9.6.2. Middle East & Africa: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
    • 9.6.3. Middle East & Africa: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
    • 9.6.4. Middle East & Africa: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
    • 9.6.5. Rare Disease Genetic Testing Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
      • 9.6.5.2. Saudi Arabia: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
      • 9.6.5.3. Saudi Arabia: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
      • 9.6.5.4. Saudi Arabia: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
    • 9.6.6. Rare Disease Genetic Testing Market - South Africa
      • 9.6.6.1. South Africa: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
      • 9.6.6.2. South Africa: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
      • 9.6.6.3. South Africa: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
      • 9.6.6.4. South Africa: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
    • 9.6.7. Rare Disease Genetic Testing Market - Israel
      • 9.6.7.1. Israel: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
      • 9.6.7.2. Israel: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
      • 9.6.7.3. Israel: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
      • 9.6.7.4. Israel: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
    • 9.6.8. Rare Disease Genetic Testing Market - UAE
      • 9.6.8.1. UAE: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
      • 9.6.8.2. UAE: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
      • 9.6.8.3. UAE: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
      • 9.6.8.4. UAE: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
  • 9.7. Rare Disease Genetic Testing Market - Latin America
    • 9.7.1. Latin America: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
    • 9.7.2. Latin America: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
    • 9.7.3. Latin America: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
    • 9.7.4. Latin America: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
    • 9.7.5. Rare Disease Genetic Testing Market - Mexico
      • 9.7.5.1. Mexico: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
      • 9.7.5.2. Mexico: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
      • 9.7.5.3. Mexico: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
      • 9.7.5.4. Mexico: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
    • 9.7.6. Rare Disease Genetic Testing Market - Brazil
      • 9.7.6.1. Brazil: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
      • 9.7.6.2. Brazil: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
      • 9.7.6.3. Brazil: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
      • 9.7.6.4. Brazil: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
    • 9.7.7. Rare Disease Genetic Testing Market - Argentina
      • 9.7.7.1. Argentina: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
      • 9.7.7.2. Argentina: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
      • 9.7.7.3. Argentina: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
      • 9.7.7.4. Argentina: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. 3billion, Inc
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Ambry Genetics
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Artemis DNA
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Arup Laboratories
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Baylor Genetics
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Centogene N.V
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Color Genomics, Inc
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Coopersurgical, Inc
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Eurofins Scientific
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Fulgent Genetics Inc
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Genomenon
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Health Network Laboratories
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Invitae Corp
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. Laboratory Corporation of America Holdings
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development
  • 11.15. Macrogen, Inc
    • 11.15.1. Company Overview
    • 11.15.2. Financial Performance
    • 11.15.3. Product Benchmarking
    • 11.15.4. Recent Development
  • 11.16. Myriad Genetics, Inc.
    • 11.16.1. Company Overview
    • 11.16.2. Financial Performance
    • 11.16.3. Product Benchmarking
    • 11.16.4. Recent Development
  • 11.17. Opko Health, Inc
    • 11.17.1. Company Overview
    • 11.17.2. Financial Performance
    • 11.17.3. Product Benchmarking
    • 11.17.4. Recent Development
  • 11.18. Perkin Elmer, Inc
    • 11.18.1. Company Overview
    • 11.18.2. Financial Performance
    • 11.18.3. Product Benchmarking
    • 11.18.4. Recent Development
  • 11.19. PreventionGenetics
    • 11.19.1. Company Overview
    • 11.19.2. Financial Performance
    • 11.19.3. Product Benchmarking
    • 11.19.4. Recent Development
  • 11.20. Progenity, Inc
    • 11.20.1. Company Overview
    • 11.20.2. Financial Performance
    • 11.20.3. Product Benchmarking
    • 11.20.4. Recent Development
  • 11.21. Quest Diagnostics Inc.
    • 11.21.1. Company Overview
    • 11.21.2. Financial Performance
    • 11.21.3. Product Benchmarking
    • 11.21.4. Recent Development
  • 11.22. Realm IDX, Inc
    • 11.22.1. Company Overview
    • 11.22.2. Financial Performance
    • 11.22.3. Product Benchmarking
    • 11.22.4. Recent Development
  • 11.23. Strand Life Sciences.
    • 11.23.1. Company Overview
    • 11.23.2. Financial Performance
    • 11.23.3. Product Benchmarking
    • 11.23.4. Recent Development